Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant

(1) Introduction: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among immunocompromised patients with hematologic malignancies (HM) and stem cell transplants (SCT). Isavuconazole was approved by FDA as a primary therapy for Invasive Aspergillosis (IA) and Mucormycosi...

全面介绍

书目详细资料

Principais autores:	Hiba Dagher, Ray Hachem, Anne-Marie Chaftari, Ying Jiang, Shahnoor Ali, Rita Deeba, Shivan Shah, Issam Raad
格式:	Artigo
语言:	Inglês
出版:	MDPI AG 2022-01-01
丛编:	Journal of Fungi
主题:	isavuconazole invasive aspergillosis antifungal anti-mold
在线阅读:	https://www.mdpi.com/2309-608X/8/1/74
标签:	添加标签 没有标签, 成为第一个标记此记录!